Managing intellectual property to develop medicines for the world’s poorest

24 Feb 2017

Sylvie Fonteilles-Drabek, David Reddy & Timothy N. C. Wells

Nature Reviews Drug Discovery

doi:10.1038/nrd.2017.24

Abstract

It has been argued that patents impede the development and access of medicines for tropical diseases such as malaria. However, we believe that intellectual property can be a key tool to enable timely progression of drug development projects involving multiple partners and to ensure equitable access to successful products.

Read the full article.